Unicycive Therapeutics | 8-K:Unicycive公佈2024年第一季度財務業績並提供業務最新情況
Unicycive Therapeutics | 10-Q:季度報表
Unicycive Therapeutics | DEFA14A:其他
Unicycive Therapeutics | DEF 14A:股東委託書決議
Unicycive Therapeutics | ARS:年度報告
Unicycive Therapeutics | DEFA14A:其他
Unicycive Therapeutics | 4:持股變動聲明-高管 Gupta Shalabh K.
Unicycive Therapeutics | 4:持股變動聲明-高管 Gupta Pramod
Unicycive Therapeutics | 4:持股變動聲明-高管 Jermasek Douglas
Unicycive Therapeutics | 4:持股變動聲明-高管 Townsend John
Unicycive Therapeutics | PRE 14A:並購重組委托聲明
Unicycive Therapeutics | 8-K:重大事件
Unicycive Therapeutics | 10-K:年度報表
Unicycive Therapeutics | D:發行公告
Unicycive Therapeutics | 8-K:重大事件
Unicycive Therapeutics | 8-K:重大事件
Unicycive Therapeutics | 8-K:重大事件
Unicycive Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%)等
Unicycive Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Nantahala Capital Management, LLC(9.9%),Wilmot B. Harkey(9.9%)等
Unicycive Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Armistice Capital, LLC(2.73%),Steven Boyd(2.73%)
暫無數據